127 related articles for article (PubMed ID: 28975121)
1. Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India.
Haleshappa RA; Thanky AH; Kuntegowdanahalli L; Kanakasetty GB; Dasappa L; Jacob L
South Asian J Cancer; 2017; 6(3):122-124. PubMed ID: 28975121
[TBL] [Abstract][Full Text] [Related]
2. Pediatric nasopharyngeal carcinoma: Experience from a tertiary cancer center in India.
Radhakrishnan V; Kumar P; Totadri S; Ganesan P; Selvaluxmy G; Ganesan T; Dhanushkodi M; Sagar T
Indian J Cancer; 2016; 53(3):377-380. PubMed ID: 28244463
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
[TBL] [Abstract][Full Text] [Related]
4. Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis.
Liao JF; Zhang Q; Du XJ; Lan M; Liu S; Xia YF; Cai XY; Luo W
Cancer Commun (Lond); 2019 Jun; 39(1):40. PubMed ID: 31248459
[TBL] [Abstract][Full Text] [Related]
5. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L; Zhang YW; Hu CS; Guo Y
Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
[TBL] [Abstract][Full Text] [Related]
7. Outpatient weekly chemotherapy in patients with nasopharyngeal carcinoma and distant metastasis.
Lin JC; Jan JS; Hsu CY
Cancer; 1998 Aug; 83(4):635-40. PubMed ID: 9708925
[TBL] [Abstract][Full Text] [Related]
8. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
[TBL] [Abstract][Full Text] [Related]
9. [Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma].
Hu QY; Liu P; Wang L; Fu ZF
Ai Zheng; 2007 Apr; 26(4):394-7. PubMed ID: 17430659
[TBL] [Abstract][Full Text] [Related]
10. Concurrent weekly docetaxel chemotherapy in combination with radiotherapy for stage III and IVA-B nasopharyngeal carcinoma.
Wei WH; Cai XY; Xu T; Zhang GY; Wu YF; Feng WN; Lin L; Deng YM; Lu QX; Huang ZL
Asian Pac J Cancer Prev; 2012; 13(3):785-9. PubMed ID: 22631648
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients.
Nakahara S; Hanamoto A; Seo Y; Miyaguchi S; Yamamoto Y; Tomiyama Y; Yoshii T; Takenaka Y; Yoshioka Y; Isohashi F; Ogawa K; Inohara H
Jpn J Clin Oncol; 2016 Oct; 46(10):903-910. PubMed ID: 27474126
[TBL] [Abstract][Full Text] [Related]
12. A preliminary result of concurrent chemoradiation with weekly cisplatin in elderly nasopharyngeal carcinoma patients.
Ho HC; Su YC; Lee MS; Hsiao SH; Hwang JH; Lee CC; Hung SK
Acta Otolaryngol; 2008 Aug; 128(8):930-5. PubMed ID: 18607921
[TBL] [Abstract][Full Text] [Related]
13. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
14. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
[TBL] [Abstract][Full Text] [Related]
15. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.
Lee AW; Tung SY; Ngan RK; Chappell R; Chua DT; Lu TX; Siu L; Tan T; Chan LK; Ng WT; Leung TW; Fu YT; Au GK; Zhao C; O'Sullivan B; Tan EH; Lau WH
Eur J Cancer; 2011 Mar; 47(5):656-66. PubMed ID: 21112774
[TBL] [Abstract][Full Text] [Related]
16. Neo-adjuvant Docetaxel and Cisplatin followed by concurrent Cisplatin with radiation therapy in treatment of locally advanced nasopharyngeal carcinoma.
Hassan E; Galal K; Esmat E
Gulf J Oncolog; 2008 Jan; (3):46-53. PubMed ID: 20084797
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemoradiation in locally advanced head and neck cancers: a comparative study of weekly Paclitaxel versus Cisplatin-based regimen.
Essa HH; Azzam M
J Egypt Natl Canc Inst; 2010 Sep; 22(3):165-73. PubMed ID: 21863067
[TBL] [Abstract][Full Text] [Related]
18. A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study.
Meng DF; Sun R; Peng LX; Huang YS; Yang Q; Luo DH; Hu WH; Xie FY; Luo W; Zhao C; Guo L; Mai HQ; Chen MY; Xie P; Zheng LS; Yang JP; Mei Y; Qiang YY; Xu L; Li CZ; Huang BJ; Qian CN; Sun R
J Cancer; 2018; 9(1):92-99. PubMed ID: 29290773
[No Abstract] [Full Text] [Related]
19. Weekly paclitaxel with concurrent radiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Hu W; Ding W; Yang H; Shao M; Wang B; Wang J; Wu S; Wu S; Jin L; Ma CC
Radiother Oncol; 2009 Dec; 93(3):488-91. PubMed ID: 19679366
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
Qiu WZ; Huang PY; Shi JL; Xia HQ; Zhao C; Cao KJ
Chin J Cancer; 2016 Jan; 35():2. PubMed ID: 26739148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
